Suchergebnisse - "Menzies-Gow, Andrew"

PubPharm (31)

1

Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL) : a randomised, multicentre, open-label, phase 4 study

enthalten in: Lancet (London, England) | 2024

von Jackson, D. | Heaney, L. | Humbert, M. | +41

ErratumIn: Lancet. 2024 Mar 23;403(10432):1140. - PMID 38521558

2

Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both

enthalten in: Allergy | 2023

von Pfeffer, P. | Ali, N. | Murray, R. | +66

3

Efficacy of Tezepelumab in Severe, Uncontrolled Asthma : Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials

enthalten in: American journal of respiratory and critical care medicine | 2023

von Corren, J. | Menzies-Gow, A. | Chupp, G. | +13

CommentIn: Ann Intern Med. 2023 Nov;176(11):JC128. - PMID 37931261

4

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION) : a randomised, placebo-controlled extension study

enthalten in: The Lancet. Respiratory medicine | 2023

von Menzies-Gow, A. | Wechsler, M. | Brightling, C. | +114

CommentIn: Lancet Respir Med. 2023 Jan 23;:. - PMID 36702145

5

Long-term efficacy of dupilumab in asthma with or without chronic rhinosinusitis and nasal polyps

enthalten in: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | 2023

von Berger, P. | Menzies-Gow, A. | Peters, A. | +9

6

A Response to : Letter to the Editor Regarding "Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab"

enthalten in: Advances in therapy | 2022

von Menzies-Gow, A. | Hoyte, F. | Price, D. | +7

CommentOn: Adv Ther. 2022 May;39(5):2065-2084. - PMID 35287231

7

Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE) : a randomised, placebo-controlled, phase 3 study

enthalten in: The Lancet. Respiratory medicine | 2022

von Wechsler, M. | Menzies-Gow, A. | Brightling, C. | +72

ErratumIn: Lancet Respir Med. 2022 Apr 5;:. - PMID 35395206

8

Benralizumab Effectiveness in Severe Asthma Is Independent of Previous Biologic Use

enthalten in: The journal of allergy and clinical immunology. In practice | 2022

von Jackson, D. | Burhan, H. | Menzies-Gow, A. | +7

9

Clinical Remission in Severe Asthma : A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab

enthalten in: Advances in therapy | 2022

von Menzies-Gow, A. | Hoyte, F. | Price, D. | +7

CommentIn: Adv Ther. 2022 Aug;39(8):3857-3861. - PMID 35731338

10

Tezepelumab compared with other biologics for the treatment of severe asthma : a systematic review and indirect treatment comparison

enthalten in: Journal of medical economics | 2022

von Menzies-Gow, A. | Steenkamp, J. | Singh, S. | +6